Core Points - The company, Chuangye Huikang (300451.SZ), announced a provision for credit impairment and asset impairment totaling 93,315,250.16 yuan for the first half of 2025 [1] Summary by Category Credit Impairment Provisions - Accounts receivable bad debt provision amounted to 75,263,685.70 yuan [1] - Bad debt provision for notes receivable was -1,739,107.83 yuan [1] - Other receivables bad debt provision was -373,161.48 yuan [1] Asset Impairment Provisions - Contract asset impairment provision was 4,471,811.46 yuan [1] - Inventory write-down provision totaled 15,692,022.31 yuan [1] Financial Impact - The total provision will reduce the profit for the year 2025 by 93,315,250.16 yuan [1] - This provision will also correspondingly decrease the company's net asset value at the end of the reporting period [1]

Financial Performance - The company's operating revenue for the reporting period is approximately 576.68 million yuan, showing a 72% increase [1] - The net profit attributable to shareholders is a loss of approximately 80.55 million yuan, while the net profit after deducting non-recurring gains and losses is a loss of approximately 94.62 million yuan [1] - The net cash flow from operating activities is a negative 177.86 million yuan, representing a 19% decrease [1] - The basic and diluted earnings per share are both negative 0.05 yuan [1] - The weighted average return on equity is negative 1.84%, a decrease of 2.43 percentage points year-on-year [20] Asset and Liability Overview - As of the end of the reporting period, total assets amount to approximately 5.54 billion yuan, an increase of 5.66% [1] - The net assets attributable to shareholders are approximately 4.34 billion yuan, reflecting a 4.41% increase [1] - The company's cash and cash equivalents decreased by 28.76% compared to the end of the previous year, while accounts receivable increased by 6.24% [33] - The company's current ratio is 2.68 and the quick ratio is 2.34 as of the end of the reporting period [45] Shareholder Structure - The largest shareholder is Ge Hang, holding 13.24% of the shares, with no change in holding [49] - Notably, 10.22% of the company's shares are under pledge, with Ge Hang pledging 205 million shares, which is 100% of his holdings [49] Valuation Metrics - As of August 26, the company's price-to-earnings ratio (TTM) is approximately -31.65, the price-to-book ratio (LF) is approximately 2.05, and the price-to-sales ratio (TTM) is approximately 7 [1]

Financial Performance - In the first half of 2025, the company reported total revenue of 577 million, a year-on-year decrease of 20.65% [1] - The net loss attributable to shareholders was 80.55 million, compared to a loss of 27.37 million in the same period last year, indicating an expanded loss [1] Business Operations - The company facilitated 190,000 prescriptions through its internet hospital, with a 140% increase in traditional Chinese medicine prescriptions [1] - The company has partnered with over 250 institutions for commercial insurance [1] - The number of merchants using the aggregation payment service reached 2,000, with 48 million new transactions and a transaction volume of 8.5 billion [1] - The cloud nursing service collaborated with over 250 institutions, employing more than 7,600 nurses and processing 93,800 orders [1] Platform Development - The company is responsible for the "Health Wenzhou" platform, which has served over 2 million people, with more than 400,000 app downloads and 700,000 mini-program users [1] - The platform has integrated over 300 institutions and created more than 30 service scenarios, with nearly 2 million appointment bookings [1] - The "Health Zhongshan" app has 3.3 million users, with over 530,000 followers on its public account and 1.45 million mini-program followers [1] - The company activated 12.6 million "One Card" accounts, uploading nearly 50 million source records [1] Company Background - Founded in 1997, the company is one of the earliest software suppliers in the medical and health information sector in China [2] - The company has implemented nearly 20,000 medical and health information projects, serving over 7,000 industry users and covering public health projects across more than 370 districts and counties [2] - The company has accumulated approximately 300 million resident health records [2]

Core Viewpoint - The company reported a significant decline in revenue and incurred a net loss for the first half of 2025, indicating financial challenges ahead [1] Financial Performance - The company's operating revenue for the first half of 2025 was 577 million, representing a year-on-year decrease of 20.65% [1] - The net loss attributable to shareholders of the listed company was 80.55 million [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 94.62 million [1] - The basic loss per share was 0.05 yuan [1]

Group 1 - The stock of Chuangye Huikang (300451) closed at 5.75 yuan on August 26, 2025, with a slight increase of 0.17% and a turnover rate of 4.31% [1] - The net outflow of main funds was 13.65 million yuan, accounting for 3.6% of the total turnover, while retail investors saw a net inflow of 30.91 million yuan, representing 8.15% of the total turnover [1][2] - Over the past five days, the stock experienced fluctuations in fund flows, with significant net outflows from main and speculative funds on August 25, totaling 60.16 million yuan and 17.26 million yuan respectively [2] Group 2 - Chuangye Huikang's total market value is 8.907 billion yuan, which is below the software development industry average of 14.674 billion yuan, ranking 77th out of 194 [3] - The company reported a net profit of -80.55 million yuan, with a net profit margin of -12.54%, which is better than the industry average of -16.8%, ranking 119th out of 194 [3] - The company's main revenue for Q1 2025 was 290 million yuan, a year-on-year decrease of 22.67%, and the net profit attributable to shareholders was -15.64 million yuan, a decline of 226.6% [3] Group 3 - Chuangye Huikang has shifted its main business focus from product development and sales to system construction, services, and operations, including areas such as smart healthcare and medical big data [3] - The company has received one buy rating from an institution in the last 90 days, with an average target price of 5.47 yuan [4]

关于股东质押股份被司法再冻结的公告 证券代码：300451 证券简称：创业慧康 公告编号：2025-044 创业慧康科技股份有限公司 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 重要内容提示： 创业慧康科技股份有限公司（以下简称"公司"）5%以上股东葛航先生持 有公司 158,291,382 股，占公司总股本的 10.22%；其本次被司法再冻结股份均 为质押冻结股份，数量为 22,000,000 股，占公司总股本的 1.42%。 公司自 2023 年 8 月 25 日处于无控股股东、无实际控制人状态，葛航先生 不属于公司控股股东、实际控制人，不参与公司经营管理，其所持公司股份被 司法再冻结事项不会导致公司控制权发生变更，亦不会对公司日常经营和管理 造成影响。 葛航先生答复，本次司法再冻结系因相关质权人申请法院财产保全所致， 葛航表示其目前整体资产足以覆盖全部负债，其正在积极与相关质权人协商， 并筹措资金用于化解债务。 2、是否存在非经营性资金占用、违规担保等侵害上市公司利益的情形。 葛航先生答复，不存在相关情形。 经葛航先生通知，其于近日收到法院相关文书，获悉 ...

创业慧康科技股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位：万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司的关 | 上市公司核算的会 | 2025 年期初占用 | 2025 年半年度占用 | 2025 年半年度占用资 | 2025 年半年度偿还 | 2025 年上半年期末 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | 累计发生金额（不含 | | | | | | | | | 联关系 | 计科目 | 资金余额 | 利息） | 金的利息（如有） | 累计发生金额 | 占用资金余额 | | | | 控股股东、实际控制人及其 | | | | | | | | | | | | 附属企业 | | | | | | | | | | | | 小计 | | | | | | | | | | | | 前控股股东、实际控制人及 | | | | | | | | | | | | 其附属企业 | | | | | | | | | | | | ...

证券代码：300451 证券简称：创业慧康 公告编号: 2025-043 创业慧康科技股份有限公司 关于 2025 年半年度计提信用减值准备和资产减值准备 的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"）根据《深圳证券交易所上 市公司自律监管指引第 2 号——创业板上市公司规范运作》《企业会计准则》以 及公司相关会计政策的规定，在 2025 年半年度计提了信用减值损失及资产减值 损失，现将具体情况公告如下： 一、本次计提信用减值准备和资产减值准备情况概述 1、本次计提信用减值准备和资产减值准备的原因 根据《企业会计准则》《深圳证券交易所创业板股票上市规则》等相关规定 的要求，为真实准确地反映公司截至 2025 年 6 月 30 日的财务状况和经营成果， 公司对截止 2025 年 6 月 30 日的各类资产进行了减值测试，基于谨慎性原则，对 部分资产计提信用减值准备以及资产减值准备合计人民币 93,315,250.16 元。具 体情况如下表： | | 项目 | 本期发生额（单位：元） | | --- | --- | ...

Core Insights - The document outlines the financial interactions between the listed company and its subsidiaries, including non-operating fund occupations and related party transactions [1] Group 1: Non-operating Fund Occupations - The total amount of non-operating fund occupations at the beginning of 2025 is reported as 6,526.77 million yuan, with a mid-year balance of 6,889.08 million yuan [1] - The document details various subsidiaries and their respective amounts involved in non-operating fund occupations, such as: - Nanjing Chuangye Software Co., Ltd. with 2,583.97 million yuan [1] - Guangzhou Yuewan Huikang Technology Co., Ltd. with 115.07 million yuan [1] - Hangzhou He Mei Property Management Co., Ltd. with 384.13 million yuan [1] Group 2: Related Party Transactions - The document lists the related party transactions, indicating a total of 6,045.09 million yuan at the beginning of 2025, with a mid-year balance of 6,889.08 million yuan [1] - Specific transactions include: - Tianjin Chuangjin Technology Co., Ltd. with 685.52 million yuan [1] - Zhejiang Yishan Smart Medical Research Co., Ltd. with 16.39 million yuan [1] - Chongqing Chuangyikang Software Co., Ltd. with 284.35 million yuan [1] Group 3: Financial Management - The legal representative is Zhang Lvzhen, and the accounting manager is Zheng Qi, indicating a structured financial management team [2]

证券代码：300451 证券简称：创业慧康 公告编号: 2025-043 创业慧康科技股份有限公司 关于 2025 年半年度计提信用减值准备和资产减值准备 的公告 资产减值准备 存货跌价准备 15,692,022.31 合 计 93,315,250.16 注：上述减值准备涉及的相关数据未经审计，对公司相关财务数据的最终影响将以会计师事务所年度 审计确认后的结果为准。 上述计提的资产减值损失及信用减值损失系遵照《企业会计准则》和公司相关会计政策的规定计提的 减值及坏账准备，不代表相应资产已实际发生损失。 二、本次计提信用减值准备及资产减值准备的确认标准及计提方法 公司以单项金融工具或金融工具组合为基础评估预期信用风险和计量预期 信用损失。当以金融工具组合为基础时，公司以共同风险特征为依据，将金融工 具划分为不同组合。 公司在每个资产负债表日重新计量预期信用损失，由此形成的损失准备的增 加或转回金额，作为减值损失或利得计入当期损益。对于以摊余成本计量的金融 资产，损失准备抵减该金融资产在资产负债表中列示的账面价值；对于以公允价 值计量且其变动计入其他综合收益的债权投资，公司在其他综合收益中确认其损 失准备，不抵减 ...